The Omega-3 Clinical Study Database, now in phase 2 data extraction, will one day be a searchable database of human clinical trials that examined the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), or the combination of those two long-chain omega-3s.
GOED (The Global Organization for EPA and DHA Omega-3s) started this endeavor two years ago, as Ellen Schutt, executive director, explains in this Healthy Insider Podcast, and has narrowed down 35,000 potential studies into 4,000 specifically focused on EPA/DHA that need to be categorized for demographics, dosage, intervention and outcome.
With Sandy Almendarez, content director, INSIDER, Schutt talks about the Omega-3 Clinical Study Database, including:
- Who will benefit from the database and who will have access
- How this database will be different from other research archives, such as PubMed.
- How attendees of the 2020 GOED Exchange will see sneak peek of the database.
Learn more about the Omega-3 Clinical Study Database from Aldo Bernasconi, Ph.D., director of information and research, GOED, at the GOED Exchange, Feb. 4 to 6, 2020 in Barcelona, Spain.
